237
Participants
Start Date
October 3, 2018
Primary Completion Date
January 26, 2022
Study Completion Date
December 31, 2022
Children's National Medical Center, Washington D.C.
Children's Healthcare of Atlanta/Emory, Atlanta
Augusta University Hemophilia Treatment Center, Augusta
Johns Hopkins All Children's Hospital, St. Petersburg
Vanderbilt University Medical Center, Nashville
St Jude Children's Research Hospital, Memphis
Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital, Toledo
UHHS Cleveland, Cleveland
Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis
University of Michigan Hemophilia and Coagulation Disorders, Ann Arbor
Blood Center of Wisconsin, Milwaukee
Hemophilia Outreach Center, Green Bay
Mayo Comprehensive Hemophilia Center, Rochester
Rush University Medical Center, Chicago
Kansas City Regional Hemophilia Center, Kansas City
Oklahoma Center for Bleeding and Clotting Disorders, Oklahoma City
University of Colorado Denver Hemophilia and Thrombosis Center, Aurora
Utah Center for Bleeding & Clotting Disorders at Primary Children's Hospital, Salt Lake City
Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital, Phoenix
Rady Children's Hospital San Diego, San Diego
Valley Children's Hospital, Madera
UCSF Pediatric Hemophilia Treatment Center at Mission Bay, San Francisco
Oregon Health and Science University, Portland
Connecticut Bleeding and Clotting Disorders Center, Farmington
Maine Hemophilia and Thrombosis Center, Scarborough
Boston Hemophilia Center at Children's Hospital of Boston, Boston
Collaborators (3)
CSL Behring
INDUSTRY
Octapharma
INDUSTRY
Takeda
INDUSTRY
American Thrombosis and Hemostasis Network
NETWORK